The macro picture is one I think almost everyone here agrees on.....given all the indications and the trial results to date, the involvment of Dart and Hepa, orphan diseases and everything else....the potential is massive. There are others here who understand the fundamental picture here far better than I so I won't go into detail on it.....in brief shareholders know what they have.

So if everything is so gall darned rosy....Why is the PPS under $2?

That's where the micro picture comes in. It is my opinion that retail investors have it right here about the potential for RVX's share price to explode exponentially higher. And I believe there are some very well heeled investors who want in....the ''smart money'' crowd I so often reference.

But look at the volume.....retail ''dumb'' money investors are not letting go. What do we constantly see? So many little volume trades. Here's just a snippet:

So the PPS moves up to $1.80...a climb of 2 little pennies. And then someone who doesn't want the indentity of their brokerage known sells 100 shares at $1.78.....The only trade of any size is marked W for a by-pass trade. Curious? I sure think so. In fact I would bet that 100 share sale was short.

There are somewhere around 10,000 stocks on the public markets in Canada and the US....and RVX doesn't have much of a profile, even within the biotech space. That will change I believe, but only when this ''smart money'' crowd is able to establish a large enough position to profit from the climb.